Bright purple and orange lactobacillus bacteria.
How a Specific Gut Bacterium May Cause Type 1 Diabetes
A bacterium that produces an insulin-like peptide can give mice type 1 diabetes, and infection with the microbe seems to predict the onset of the disease in humans, a study finds.
How a Specific Gut Bacterium May Cause Type 1 Diabetes
How a Specific Gut Bacterium May Cause Type 1 Diabetes

A bacterium that produces an insulin-like peptide can give mice type 1 diabetes, and infection with the microbe seems to predict the onset of the disease in humans, a study finds.

A bacterium that produces an insulin-like peptide can give mice type 1 diabetes, and infection with the microbe seems to predict the onset of the disease in humans, a study finds.

type 1 diabetes
A twisted and folded illustration of single-stranded RNA in front of a blue background.
Deficient RNA Editing Implicated in Inflammatory Disease 
Alejandra Manjarrez | Aug 5, 2022
Genetic variants that reduce the editing levels of double-stranded RNA are associated with autoimmune and immune-mediated conditions, a study finds.
Micrograph of a beta cell, where insulin granules are shown as blue small balls, mitochondria are colored green, and a fraction of the cell nucleus appears in purple.
Diabetes Linked to Malnutrition Is Metabolically Unique: Study
Alejandra Manjarrez | Jun 16, 2022
Results from a small sample of Indian males suggest that lean individuals with a history of malnutrition suffer from a distinct type of diabetes characterized by a defect in insulin secretion.
diabetes, type 1, type 2, COVID-19, SARS-CoV-2, coronavirus, pandemic, registry
A Global Registry Aims to See if COVID-19 Causes Diabetes
Asher Jones | Mar 19, 2021
Researchers have collected hundreds of COVID-19–related diabetes case reports since August of last year, in hopes of teasing apart the complex links between the two diseases.
Roger Unger, diabetes, metabolic syndrome, type 1, type 2, glucagon, insulin, leptin, lipotoxicity, University of Texas Southwestern, endocrinology, hormone, obituary
Roger Unger, Endocrinologist and Authority on Diabetes, Dies
Amanda Heidt | Sep 4, 2020
The University of Texas Southwestern scientist studied the roles of glucagon and insulin in regulating blood glucose, leading to several successful treatments.
type 1 diabetes
Biotechs Race to Develop Stem Cell Treatments for Diabetes
Eric Bender | Jul 15, 2019
Insulin-producing cells grown in the lab could offer a functional cure for the disease.
x lymphocyte DE cell immune immunology t cell b cell type 1 diabetes
Novel Type of Immune Cell Discovered in Type 1 Diabetes Patients
Katarina Zimmer | May 30, 2019
A rogue hybrid lymphocyte, bearing characteristics of both B and T cells, may play a role in driving autoimmunity in the disease, although the mechanism is far from clear.
Human Pancreas Cells Can Be Made to Produce Insulin
Jef Akst | Feb 14, 2019
When implanted into mice, the “pseudo-islets” helped treat the animals’ diabetes symptoms.
Immune Response to Gut Microbes Linked to Diabetes Risk
Abby Olena | Feb 1, 2019
Researchers find that it’s not just high-risk genes, but how children’s bodies respond to their own intestinal microbiota that relates to future diagnoses of type 1 diabetes.
Drop in Infant Type 1 Diabetes Linked to Rotavirus Vaccination
Catherine Offord | Jan 23, 2019
Results from an observational study find that the introduction of a routine vaccine in Australia coincided with a fall in the incidence of the autoimmune condition.
Studies Unable to Reproduce Results of Two Diabetes Papers
Anna Azvolinsky | Aug 10, 2018
The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.
Reprogrammed Cells Treat Diabetes in Mice
Abby Olena | May 2, 2018
Researchers used a trio of transcription factors to transform pancreatic duct cells in vivo into β-like cells that secrete insulin and improve diabetes symptoms.
Diabetes Is Five Diseases, Not Two
Jim Daley | Mar 4, 2018
The new classification system could help improve personalized medicine approaches to the disease.
Gene Therapy Temporarily Reverses Type 1 Diabetes in Mice
Shawna Williams | Jan 4, 2018
Pancreatic cells engineered to produce insulin did not immediately provoke an immune response.
Image of the Day: Glucose Sensor 
The Scientist Staff and The Scientist Staff | Jan 2, 2018
Scientists build a biosensor skin patch for noninvasive glucose monitoring. 
Will the Noninvasive Glucose Monitoring Revolution Ever Arrive?
Catherine Offord | Oct 12, 2017
A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.
Immunotherapy Promising for Diabetes: Study
Aggie Mika | Aug 9, 2017
A small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.
Bioengineered ‘Pancreas’ Effective in First Patient
Aggie Mika | May 11, 2017
The diabetic volunteer continued to produce insulin one year after she received a transplant of abdominal islet cells.
Antibiotic Therapy During Infancy Increases Type 1 Diabetes Risk in Mice
Alison F. Takemura | Aug 22, 2016
Three therapeutic doses administered during early life disturb the animals’ microbiomes and lead to enduring changes in the immune systems of non-obese diabetic mice, researchers report.
Book Excerpt from Blood Sugar
Anthony Ryan Hatch | Jun 30, 2016
Author Anthony Ryan Hatch relays his personal experience with metabolic syndrome.